• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇激酶-1在体外被组织蛋白酶B切割:蛋白酶初始切割位点的鉴定。

Sphingosine kinase-1 is cleaved by cathepsin B in vitro: identification of the initial cleavage sites for the protease.

作者信息

Taha Tarek A, El-Alwani Mazen, Hannun Yusuf A, Obeid Lina M

机构信息

Division of General Internal Medicine, Ralph H. Johnson Veterans Administration Hospital, Charleston, SC 29401, USA.

出版信息

FEBS Lett. 2006 Nov 13;580(26):6047-54. doi: 10.1016/j.febslet.2006.09.070. Epub 2006 Oct 12.

DOI:10.1016/j.febslet.2006.09.070
PMID:17064696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1732625/
Abstract

Previous work has identified sphingosine kinase-1 (SK1) as a substrate for the cysteine protease cathepsin B in vitro. In this study, the mechanism of SK1 cleavage by cathepsin B was investigated. We identified two initial cleavage sites for the protease, the first at histidine 122 and the second at arginine 199. Mutation analysis showed that replacement of histidine 122 with a tyrosine maintained the activity of SK1 while significantly reducing cleavage by cathepsin B at the initial cleavage site. The efficacy of cleavage of SK1 at arginine 199, however, was not affected. These studies demonstrate that SK1 is cleaved by cathepsin B in a sequential manner after basic amino acids, and that the initial cleavages at the two identified sites occur independently of each other.

摘要

先前的研究已确定鞘氨醇激酶-1(SK1)在体外是半胱氨酸蛋白酶组织蛋白酶B的底物。在本研究中,对组织蛋白酶B切割SK1的机制进行了研究。我们确定了该蛋白酶的两个初始切割位点,第一个位于组氨酸122处,第二个位于精氨酸199处。突变分析表明,用酪氨酸取代组氨酸122可维持SK1的活性,同时显著减少组织蛋白酶B在初始切割位点的切割。然而,组织蛋白酶B对精氨酸199处SK1的切割效率不受影响。这些研究表明,SK1在碱性氨基酸之后被组织蛋白酶B依次切割,并且在两个已确定位点的初始切割相互独立发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/d860f1933c4a/nihms13785f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/00de2db92ada/nihms13785f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/008cb217a347/nihms13785f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/343805ae9b4f/nihms13785f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/12e37618df43/nihms13785f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/54b8777cb0d4/nihms13785f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/d860f1933c4a/nihms13785f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/00de2db92ada/nihms13785f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/008cb217a347/nihms13785f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/343805ae9b4f/nihms13785f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/12e37618df43/nihms13785f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/54b8777cb0d4/nihms13785f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/1732625/d860f1933c4a/nihms13785f6.jpg

相似文献

1
Sphingosine kinase-1 is cleaved by cathepsin B in vitro: identification of the initial cleavage sites for the protease.鞘氨醇激酶-1在体外被组织蛋白酶B切割:蛋白酶初始切割位点的鉴定。
FEBS Lett. 2006 Nov 13;580(26):6047-54. doi: 10.1016/j.febslet.2006.09.070. Epub 2006 Oct 12.
2
Tumor necrosis factor induces the loss of sphingosine kinase-1 by a cathepsin B-dependent mechanism.肿瘤坏死因子通过组织蛋白酶B依赖性机制诱导鞘氨醇激酶-1缺失。
J Biol Chem. 2005 Apr 29;280(17):17196-202. doi: 10.1074/jbc.M413744200. Epub 2005 Feb 14.
3
Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.硕大利什曼原虫组织蛋白酶B样半胱氨酸蛋白酶S2亚位点的表达与改变
Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):113-7.
4
Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.与组织蛋白酶B、L和H相比,激素原硫醇蛋白酶(PTP)的独特性质:PTP作为一种新型半胱氨酸蛋白酶的证据。
Arch Biochem Biophys. 1994 Oct;314(1):171-7. doi: 10.1006/abbi.1994.1426.
5
Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1.鞘氨醇激酶 1 向质膜的易位是由钙和整合素结合蛋白 1 介导的。
J Biol Chem. 2010 Jan 1;285(1):483-92. doi: 10.1074/jbc.M109.068395. Epub 2009 Oct 23.
6
The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1.伴侣蛋白CCT/TRiC是鞘氨醇激酶1成熟所必需的。
Int J Biochem Cell Biol. 2009 Apr;41(4):822-7. doi: 10.1016/j.biocel.2008.08.012. Epub 2008 Aug 14.
7
S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.S2'底物特异性以及组氨酸110和组氨酸111在人组织蛋白酶B外肽酶活性中的作用。
Biochem J. 2002 Feb 1;361(Pt 3):613-9. doi: 10.1042/0264-6021:3610613.
8
HSP-70 mitigates LPS/SKI-induced cell damage by increasing sphingosine kinase 1 (SK1).热休克蛋白 70 通过增加鞘氨醇激酶 1(SK1)减轻 LPS/SKI 诱导的细胞损伤。
Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):1-7. doi: 10.1016/j.prostaglandins.2009.12.006. Epub 2010 Feb 1.
9
Selection of an Amino Acid Site with One of the Fastest Cleavage Kinetics by the Endosomal Protease Cathepsin B for Potential Use in Drug Delivery Systems.通过内体蛋白酶 Cathepsin B 选择具有最快裂解动力学之一的氨基酸位点,用于潜在的药物递送系统。
Dokl Biochem Biophys. 2023 Apr;509(1):78-80. doi: 10.1134/S1607672922600221. Epub 2023 Jun 20.
10
Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1.转铁蛋白受体 1 的表达增强促进了鞘氨醇激酶 1 的致癌信号。
Oncogene. 2014 Nov 27;33(48):5559-68. doi: 10.1038/onc.2013.502. Epub 2013 Nov 25.

引用本文的文献

1
Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma.开发用于治疗胶质母细胞瘤的靶向性SN-38偶联物。
ACS Omega. 2024 Jan 4;9(2):2615-2628. doi: 10.1021/acsomega.3c07486. eCollection 2024 Jan 16.
2
Mass Spectrometry Detects Sphingolipid Metabolites for Discovery of New Strategy for Cancer Therapy from the Aspect of Programmed Cell Death.质谱法检测鞘脂代谢物以从程序性细胞死亡方面发现癌症治疗新策略。
Metabolites. 2023 Jul 20;13(7):867. doi: 10.3390/metabo13070867.
3
Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail.阿霉素诱导的鞘氨醇激酶 1 上调通过稳定 Snail 产生血管生成反应。
FASEB J. 2023 Mar;37(3):e22787. doi: 10.1096/fj.202201066R.
4
Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range.组织蛋白酶 B 二肽基羧基肽酶和内肽酶活性在较宽的 pH 范围内均有表现。
Biochemistry. 2022 Sep 6;61(17):1904-1914. doi: 10.1021/acs.biochem.2c00358. Epub 2022 Aug 18.
5
CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.CST6 蛋白及其肽段通过抑制 CTSB 活性和破骨细胞生成来抑制乳腺癌骨转移。
Theranostics. 2021 Oct 11;11(20):9821-9832. doi: 10.7150/thno.62187. eCollection 2021.
6
The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.鞘氨醇激酶 1 的致瘤作用及其潜在的治疗靶点。
Cancer Control. 2020 Jan-Dec;27(1):1073274820976664. doi: 10.1177/1073274820976664.
7
Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid.生物活性神经鞘脂:Lina M. Obeid 博士实验室的进展和贡献。
Cell Signal. 2021 Mar;79:109875. doi: 10.1016/j.cellsig.2020.109875. Epub 2020 Dec 5.
8
Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.p53 对恶性细胞和肿瘤微环境中溶血磷脂信号的失调调控。
Cell Signal. 2021 Feb;78:109850. doi: 10.1016/j.cellsig.2020.109850. Epub 2020 Nov 28.
9
The Relationship of Sphingosine Kinase 1 With Pyroptosis Provides a New Strategy for Tumor Therapy.鞘氨醇激酶 1 与细胞焦亡的关系为肿瘤治疗提供了新策略。
Front Immunol. 2020 Oct 2;11:574990. doi: 10.3389/fimmu.2020.574990. eCollection 2020.
10
Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants.用于稳定烟草(Nicotiana tabacum)植株中表达的重组单克隆抗体的定点诱变
FASEB J. 2016 Apr;30(4):1590-8. doi: 10.1096/fj.15-283226. Epub 2015 Dec 28.

本文引用的文献

1
Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells.小窝蛋白-1介导组织蛋白酶B、尿激酶型纤溶酶原激活物原及其细胞表面受体在人结肠癌细胞中的表达和定位。
J Cell Sci. 2005 Apr 1;118(Pt 7):1493-503. doi: 10.1242/jcs.02278. Epub 2005 Mar 15.
2
Tumor necrosis factor induces the loss of sphingosine kinase-1 by a cathepsin B-dependent mechanism.肿瘤坏死因子通过组织蛋白酶B依赖性机制诱导鞘氨醇激酶-1缺失。
J Biol Chem. 2005 Apr 29;280(17):17196-202. doi: 10.1074/jbc.M413744200. Epub 2005 Feb 14.
3
Asp177 in C4 domain of mouse sphingosine kinase 1a is important for the sphingosine recognition.小鼠鞘氨醇激酶1a的C4结构域中的天冬氨酸177对鞘氨醇的识别很重要。
FEBS Lett. 2004 Dec 3;578(1-2):106-10. doi: 10.1016/j.febslet.2004.10.081.
4
Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death.组织蛋白酶B的外显子跳跃:溶酶体肽酶的线粒体靶向引发细胞死亡。
J Biol Chem. 2004 Sep 24;279(39):41012-7. doi: 10.1074/jbc.M405333200. Epub 2004 Jul 15.
5
Multiple cell death pathways as regulators of tumour initiation and progression.多种细胞死亡途径作为肿瘤起始和进展的调节因子。
Oncogene. 2004 Apr 12;23(16):2746-56. doi: 10.1038/sj.onc.1207513.
6
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.在HeLa细胞中选择性破坏溶酶体可触发由多种木瓜蛋白酶样溶酶体组织蛋白酶切割Bid介导的细胞凋亡。
J Biol Chem. 2004 Jan 30;279(5):3578-87. doi: 10.1074/jbc.M308347200. Epub 2003 Oct 27.
7
Pericellular cathepsin B and malignant progression.细胞周围组织蛋白酶B与恶性进展
Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):271-86. doi: 10.1023/a:1023007717757.
8
The nucleotide-binding site of human sphingosine kinase 1.人类鞘氨醇激酶1的核苷酸结合位点。
J Biol Chem. 2002 Dec 20;277(51):49545-53. doi: 10.1074/jbc.M206687200. Epub 2002 Oct 18.
9
PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA).蛋白激酶C依赖性激活鞘氨醇激酶1并转位至质膜。佛波酯(PMA)诱导细胞外释放鞘氨醇-1-磷酸。
J Biol Chem. 2002 Sep 20;277(38):35257-62. doi: 10.1074/jbc.M203033200. Epub 2002 Jul 17.
10
Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B.人乳腺成纤维细胞与I型胶原蛋白的相互作用会增加组织蛋白酶B前体的分泌。
J Biol Chem. 2002 Aug 30;277(35):32220-7. doi: 10.1074/jbc.M204708200. Epub 2002 Jun 18.